1. Home
  2. BLIN vs XBIO Comparison

BLIN vs XBIO Comparison

Compare BLIN & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

N/A

Current Price

$0.85

Market Cap

9.2M

Sector

Technology

ML Signal

N/A

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$3.03

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLIN
XBIO
Founded
2000
N/A
Country
United States
United States
Employees
N/A
2
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
7.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BLIN
XBIO
Price
$0.85
$3.03
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$4.62
N/A
AVG Volume (30 Days)
31.9K
25.8K
Earning Date
02-12-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,568,000.00
N/A
Revenue This Year
$22.67
$2.81
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$1.90
52 Week High
$2.22
$13.93

Technical Indicators

Market Signals
Indicator
BLIN
XBIO
Relative Strength Index (RSI) 47.01 58.57
Support Level $0.69 $2.64
Resistance Level $0.87 $3.12
Average True Range (ATR) 0.05 0.26
MACD -0.01 0.04
Stochastic Oscillator 12.51 62.20

Price Performance

Historical Comparison
BLIN
XBIO

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: